Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors

Background & Aims Metastatic gastrointestinal neuroendocrine tumors (NETs) frequently are refractory to chemotherapy. Chemoresistance in various malignancies has been attributed to cancer stem cells (CSCs). We sought to identify gastrointestinal neuroendocrine CSCs (N-CSCs) in surgical specimens...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Gaur, Puja (author)
مؤلفون آخرون: Sceusi, Eric (author), Samuel, Shaija (author), Xia, Ling (author), Zhou, Yunfei (author), Lu, Jia (author), Tozzi, Federico (author), Lopez-Berestein, Gabriel (author), Vivas-Mejia, Pablo (author), Fleming, Jason (author), Abdalla, Eddie (author), Curley, Steven (author), Vauthey, Jean-Nicolas (author), Sood, Anil (author), Yao, James (author), Ellis, Lee (author)
التنسيق: article
منشور في: 2011
الوصول للمادة أونلاين:http://hdl.handle.net/10725/2635
http://www.sciencedirect.com/science/article/pii/S0016508511010705
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513459007258624
author Gaur, Puja
author2 Sceusi, Eric
Samuel, Shaija
Xia, Ling
Zhou, Yunfei
Lu, Jia
Tozzi, Federico
Lopez-Berestein, Gabriel
Vivas-Mejia, Pablo
Fleming, Jason
Abdalla, Eddie
Curley, Steven
Vauthey, Jean-Nicolas
Sood, Anil
Yao, James
Ellis, Lee
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Gaur, Puja
Sceusi, Eric
Samuel, Shaija
Xia, Ling
Zhou, Yunfei
Lu, Jia
Tozzi, Federico
Lopez-Berestein, Gabriel
Vivas-Mejia, Pablo
Fleming, Jason
Abdalla, Eddie
Curley, Steven
Vauthey, Jean-Nicolas
Sood, Anil
Yao, James
Ellis, Lee
author_role author
dc.creator.none.fl_str_mv Gaur, Puja
Sceusi, Eric
Samuel, Shaija
Xia, Ling
Zhou, Yunfei
Lu, Jia
Tozzi, Federico
Lopez-Berestein, Gabriel
Vivas-Mejia, Pablo
Fleming, Jason
Abdalla, Eddie
Curley, Steven
Vauthey, Jean-Nicolas
Sood, Anil
Yao, James
Ellis, Lee
dc.date.none.fl_str_mv 2011
2015-11-19T14:05:25Z
2015-11-19T14:05:25Z
2015-11-19
dc.identifier.none.fl_str_mv 0016-5085
http://hdl.handle.net/10725/2635
Gaur, P., Sceusi, E. L., Samuel, S., Xia, L., Fan, F., Zhou, Y., ... & Ellis, L. M. (2011). Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology, 141(5), 1728-1737.
http://www.sciencedirect.com/science/article/pii/S0016508511010705
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Gastroenterology
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Background & Aims Metastatic gastrointestinal neuroendocrine tumors (NETs) frequently are refractory to chemotherapy. Chemoresistance in various malignancies has been attributed to cancer stem cells (CSCs). We sought to identify gastrointestinal neuroendocrine CSCs (N-CSCs) in surgical specimens and a NET cell line and to characterize novel N-CSC therapeutic targets. Methods Human gastrointestinal NETs were evaluated for CSCs using the Aldefluor (Stemcell Technologies, Vancouver, Canada) assay. An in vitro, sphere-forming assay was performed on primary NET cells. CNDT2.5, a human midgut carcinoid cell line, was used for in vitro (sphere-formation) and in vivo (tumorigenicity assays) CSC studies. N-CSC protein expression was characterized using Western blotting. In vivo, systemic short interfering RNA administration targeted Src. Results By using the Aldefluor assay, aldehyde dehydrogenase–positive (ALDH+) cells comprised 5.8% ± 1.4% (mean ± standard error of the mean) of cells from 19 patient samples. Although many primary cell lines failed to grow, CNDT96 ALDH+ cells formed spheres in anchorage-independent conditions, whereas ALDH- cells did not. CNDT2.5 ALDH+ cells formed spheres, whereas ALDH- cells did not. In vivo, ALDH+ CNDT2.5 cells generated more tumors, with shorter latency than ALDH- or sham-sorted cells. Compared with non-CSCs, ALDH+ cells demonstrated increased expression of activated Src, Erk, Akt, and mammalian target of rapamycin (mTOR). In vivo, anti-Src short interfering RNA treatment of ALDH+ tumors reduced tumor mass by 91%. Conclusions CSCs are present in NETs, as shown by in vitro sphere formation and in vivo tumorigenicity assays. Src was activated in N-CSCs and represents a potential therapeutic target in gastrointestinal NETs.
eu_rights_str_mv openAccess
format article
id LAURepo_8fee968dc69574cc9bef7a931d50573c
identifier_str_mv 0016-5085
Gaur, P., Sceusi, E. L., Samuel, S., Xia, L., Fan, F., Zhou, Y., ... & Ellis, L. M. (2011). Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology, 141(5), 1728-1737.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/2635
publishDate 2011
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine TumorsGaur, PujaSceusi, EricSamuel, ShaijaXia, LingZhou, YunfeiLu, JiaTozzi, FedericoLopez-Berestein, GabrielVivas-Mejia, PabloFleming, JasonAbdalla, EddieCurley, StevenVauthey, Jean-NicolasSood, AnilYao, JamesEllis, LeeBackground & Aims Metastatic gastrointestinal neuroendocrine tumors (NETs) frequently are refractory to chemotherapy. Chemoresistance in various malignancies has been attributed to cancer stem cells (CSCs). We sought to identify gastrointestinal neuroendocrine CSCs (N-CSCs) in surgical specimens and a NET cell line and to characterize novel N-CSC therapeutic targets. Methods Human gastrointestinal NETs were evaluated for CSCs using the Aldefluor (Stemcell Technologies, Vancouver, Canada) assay. An in vitro, sphere-forming assay was performed on primary NET cells. CNDT2.5, a human midgut carcinoid cell line, was used for in vitro (sphere-formation) and in vivo (tumorigenicity assays) CSC studies. N-CSC protein expression was characterized using Western blotting. In vivo, systemic short interfering RNA administration targeted Src. Results By using the Aldefluor assay, aldehyde dehydrogenase–positive (ALDH+) cells comprised 5.8% ± 1.4% (mean ± standard error of the mean) of cells from 19 patient samples. Although many primary cell lines failed to grow, CNDT96 ALDH+ cells formed spheres in anchorage-independent conditions, whereas ALDH- cells did not. CNDT2.5 ALDH+ cells formed spheres, whereas ALDH- cells did not. In vivo, ALDH+ CNDT2.5 cells generated more tumors, with shorter latency than ALDH- or sham-sorted cells. Compared with non-CSCs, ALDH+ cells demonstrated increased expression of activated Src, Erk, Akt, and mammalian target of rapamycin (mTOR). In vivo, anti-Src short interfering RNA treatment of ALDH+ tumors reduced tumor mass by 91%. Conclusions CSCs are present in NETs, as shown by in vitro sphere formation and in vivo tumorigenicity assays. Src was activated in N-CSCs and represents a potential therapeutic target in gastrointestinal NETs.PublishedN/A2015-11-19T14:05:25Z2015-11-19T14:05:25Z20112015-11-19Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article0016-5085http://hdl.handle.net/10725/2635Gaur, P., Sceusi, E. L., Samuel, S., Xia, L., Fan, F., Zhou, Y., ... & Ellis, L. M. (2011). Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology, 141(5), 1728-1737.http://www.sciencedirect.com/science/article/pii/S0016508511010705enGastroenterologyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/26352019-02-26T09:37:08Z
spellingShingle Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
Gaur, Puja
status_str publishedVersion
title Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
title_full Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
title_fullStr Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
title_full_unstemmed Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
title_short Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
title_sort Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
url http://hdl.handle.net/10725/2635
http://www.sciencedirect.com/science/article/pii/S0016508511010705